What is Pfizer's change in other liabilities?

Pfizer (PFE) reported change in other liabilities of -$916.75M in Q4 2025.

How has Pfizer's change in other liabilities changed year-over-year?

Pfizer's change in other liabilities decreased by 17.7% year-over-year, from -$778.75M to -$916.75M.

What is the long-term trend for Pfizer's change in other liabilities?

Over 4 years (2021 to 2025), Pfizer's change in other liabilities has grown at a -33.5% compound annual growth rate (CAGR), from $18.72B to -$3.67B.

What does change in other liabilities mean?

Change in miscellaneous liabilities affecting operating cash flow.

Pfizer PFE Change in Other Liabilities

Change in Other Liabilities at other companies

Johnson & JohnsonJNJ

-$629M+90.3%

Merck & Co.MRK

$48.75M+498%

AmgenAMGN

-$75M+3.8%

Ionis PharmaceuticalsIONS

$21M+6,207%

Revolution Medicines, Inc.RVMD

$5.66M+63.3%

ModernaMRNA

$26M-21.2%

Other financials

Income statement

See full

Revenue$14.5B+5.4%

Gross profit$10.9B+0.3%

Net income$2.7B-9.4%

EPS (diluted)$0.47-9.6%

Balance sheet

See full

Cash & equivalents$1.8B+18.8%

Total debt$64.4B+4.9%

Total equity$90.1B-0.3%

Total assets$207.62B-0.2%

Cash flow

See full

Operating cash flow$2.6B+12.0%

CapEx$436.0M-22.7%

Free cash flow$2.2B+23.0%

Valuation

See full

Market cap$137.24B+0.6%

Enterprise value$199.91B+1.7%

P/E11.3×—

P/S2.2×0.0×

Profitability

See full

Gross margin73.5%+1.2pp

Net margin15.7%—

FCF margin18%+8.8pp

Returns & leverage

See full

Return on equity10.6%—

Debt / equity0.7×0.0×

Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingLiabilities.

The official record: Pfizer’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's change in other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pfizer's change in other liabilities?: Pfizer (PFE) reported change in other liabilities of -$916.75M in Q4 2025.
How has Pfizer's change in other liabilities changed year-over-year?: Pfizer's change in other liabilities decreased by 17.7% year-over-year, from -$778.75M to -$916.75M.
What is the long-term trend for Pfizer's change in other liabilities?: Over 4 years (2021 to 2025), Pfizer's change in other liabilities has grown at a -33.5% compound annual growth rate (CAGR), from $18.72B to -$3.67B.
What does change in other liabilities mean?: Change in miscellaneous liabilities affecting operating cash flow.